Dose booster -

New AstraZeneca COVID-19 vaccine data further support its use as third dose booster

January 26, 2022
Estimated read time 6 min read

Positive results from a preliminary analysis of an ongoing safety and immunogenicity trial (D7220C00001) showed that AstraZeneca COVID-19 vaccine (ChAdOx1-S [Recombinant]), when given as a third dose booster, increased the immune response…